Louis D. M.
- Country
- France
- Department
- Medical Oncology
Research Overview
- Evaluation of 89Zirconium-labelled Girentuximab PET-CT Imaging in Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma, and Gastroenteropancreatic Neuroendocrine Neoplasms
- Efficacy and Safety Evaluation of Lutetium (177Lu) Oxodotreotide in Advanced GEP-NETs with High Proliferation: A Phase III Randomized Study
- Comparison of mFOLFIRINOX Versus Platinum-Etoposide in First-Line Chemotherapy for Metastatic Grade 3 Gastroenteropancreatic Neuroendocrine Carcinoma
Data & Insights
Has run more than one trial at 60 of 159 partner sites.
Specializations
Advanced Solid Tumor Oncology
Focused on the treatment and management of advanced solid tumors across multiple organ sites.
- non‑small cell lung cancer
- colorectal carcinoma
- hepatocellular carcinoma
- pancreatic ductal adenocarcinoma
- metastatic breast cancer
Investigations include targeted therapies, immunotherapies, and combination regimens for refractory disease.
Hematologic Malignancies
Dedicated to clinical research in blood‑derived cancers and related disorders.
- acute myeloid leukemia
- chronic lymphocytic leukemia
- multiple myeloma
- myelodysplastic syndromes
- lymphoma
Emphasis is placed on novel agents and disease‑specific therapeutic strategies.
Rare Amyloidosis and Neuropathy
Specialized interest in hereditary protein‑misfolding disorders and their neurologic manifestations.
- transthyretin amyloidosis
- polyneuropathy
- cardiomyopathy associated with amyloid
Research aims to improve diagnostic pathways and disease‑modifying treatments.
Immunologic and Autoimmune Disorders
Exploration of immune‑mediated diseases that intersect with oncologic care.
- systemic lupus erythematosus
- ANCA‑associated vasculitis
- primary Sjögren's syndrome
- immune thrombocytopenia
- idiopathic inflammatory myopathies
Studies address disease activity control and integration with cancer therapies.
Cardiovascular and Metabolic Oncology Intersections
Investigation of cardiovascular complications and metabolic conditions linked to cancer and its treatment.
- atrial fibrillation in cancer patients
- heart failure with preserved ejection fraction
- obesity‑related cancer risk
- diabetic kidney disease
- vascular thrombosis associated with malignancy
Efforts focus on risk stratification and therapeutic optimization.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.